Mankind Pharma Acquires Remaining 10% Stake in Upakarma Ayurveda for ₹75 Lakh

$MANKIND via its wholly-owned subsidiary Mankind Lifesciences Private Limited (MLS), has acquired the remaining 10% stake in Upakarma Ayurveda Private Limited from Kaushcorp Media LLP for ₹75 lakh, completing the transaction on June 2, 2026. Upakarma Ayurveda is now a wholly-owned subsidiary of MLS and a step-down WOS of Mankind Pharma. Governance Related party transaction; executed at arm's length; no promoter interest Strategic Rationale: Operational Integration: Full ownership enables streamlined decision-making, unified branding, and consolidated supply chain management for Mankind's ayurvedic and nutraceutical portfolio. Category Expansion: Strengthens Mankind's presence in the fast-growing OTC wellness segment, complementing its prescription and consumer healthcare businesses. Margin Enhancement: Eliminating minority interest allows full capture of Upakarma's earnings and facilitates reinvestment into product innovation and distribution. Outlook: The acquisition, while modest in value, reinforces Mankind Pharma's strategy to build an integrated wellness platform. Success will depend on scaling Upakarma's product pipeline, expanding retail/e-commerce reach, and achieving synergies with Mankind's existing sales infrastructure.